Comparison of Retinal Damage in ICL Implantation Using 3D Visualization System vs. Microscope
NCT ID: NCT06966622
Last Updated: 2025-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
40 participants
INTERVENTIONAL
2025-08-25
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
3D Visualization System in Highly Myopic Cataract Operation
NCT06264830
3D Visualization System for Vitreoretinal Diseases in Highly Myopic Eyes
NCT05367193
A Comparison of Visual Function After Bilateral Implantation of Presbyopia-Correcting Intraocular Lenses (IOLs)
NCT01257217
Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation
NCT07146737
Study on the Diagnostic Efficacy of ICL Selection and Prediction Depth Model Based on Eye Images
NCT06669728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
3D visualization system
3D visualization system with coaxial illumination
operation through 3D visualization system with coaxial illumination
Microscope
microscope with standard illumination
operation through microscope with standard illumination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3D visualization system with coaxial illumination
operation through 3D visualization system with coaxial illumination
microscope with standard illumination
operation through microscope with standard illumination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 18-40 years
* Desire to improve their refractive status via ICL surgery
* Relatively stable refractive error (change ≤ 0.50 D per year for two consecutive years)
* Central anterior chamber depth ≥ 2.8 mm
* Open angles
* Corneal endothelial cell density ≥ 2000 cells/mm2.
Exclusion Criteria
* Corneal diseases,
* Glaucoma,
* Nystagmus,
* Strabismus,
* Lens subluxation,
* Severe vitreoretinal diseases,
* Other ocular diseases
* A history of ocular trauma
* A history of ocular surgery
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Fuzhou Eye Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FZYKYY-KY-2025-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.